Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Griesbacher, T.
Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors.
Pharmacology. 2000; 60(3):113-120
Doi: 10.1159/000028355
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Griesbacher Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The development of selective antagonists for bradykinin B(2) receptors has greatly advanced research on the role of the kallikrein-kinin system in acute pancreatitis. Kinins released during the course of the inflammatory injury are the major cause of the vascular symptoms, i.e. pancreatic oedema formation and its consequences, such as haemoconcentration, hypovolaemia and hypotension. Kinins are also involved in the accumulation of potentially cytotoxic factors in the pancreatic tissue. However, treatment with B(2) antagonists must begin prior to the formation of pancreatic oedema in order to inhibit or attenuate the vascular effects. Visceral pain as a possible target symptom for treatment with B(2) antagonists at later time points is suggested by the B(2) receptor-mediated activation of nociceptive afferents.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Humans -
- Kallikrein-Kinin System - drug effects
- Kallikreins - antagonists and inhibitors
- Pancreatitis, Acute Necrotizing - drug therapy
- Receptor, Bradykinin B2 - drug therapy
- Receptors, Bradykinin - antagonists and inhibitors
- Find related publications in this database (Keywords)
- bradykinin antagonists
- pancreatitis
- kallikrein-kinin system
- kallikrein inhibitors
- inflammation
- pain